| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |